DISCLAIMER: GOLDINVESTMENTCOMPANIES.COM IS AN AFFILIATED PARTNER FOR GOLDCO PRECIOUS METALS, AUGUSTA PRECIOUS METALS, AND BIRCH GOLD GROUP, PROMOTING THEIR GOLD IRA, GOLD 401K TRANSFER AND BITCOIN IRA SERVICES AND PRODUCTS.
Albert Labs CEO and chairman Dr. Michael Raymont answers some questions about psilocybin, and the growing body of evidence that suggests its efficacy as a treatment for mental health conditions.
01:02 Overview of Albert Labs
01:34 Psilocybin and the potential application in medicine
04:06 Safety profile of psilocybin
07:14 Conditions with evidence that suggest efficacy of psilocybin
10:50 Albert Labs’ research on psilocybin treatments for anxiety and depression
16:59 Regulatory environment and patient access to beneficial psilocybin treatments
24:58 Financial support for R&D
#psilocybin #investing #biotechstocks
Investing News Network (INN)
Find out more about investing by INN @
Browse our 2023 outlook reports:
Follow us Facebook:
Follow us on Twitter:
The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.